[Blood monitoring at the dawn of the 21st century].
A NEW DISCIPLINE: On January 4, 1993, the French parliament voted a law on Blood Transfusion Safety, creating a monitoring and warning system operating through a complex network and aimed at guaranteeing permanent efficacy, safety and efficiency of blood transfusion in France. A new discipline, blood monitoring was born. FUNDAMENTAL PRINCIPLES: Basically, blood monitoring is organized around two fundamental principles: blood products trackability from the donor to the recipient and mandatory reporting of all transfusion incidents. After a laborious development phase, the early results point out the immunological risk, particularly by ABO error, and the risk of bacterial contamination. AN EARLY WARNING SYSTEM: This blood monitoring system, whose primary purpose is to serve as an early warning device, must have the necessary tools to monitor, verify and analyze all available epidemiological data. Coordination of the blood monitoring system within the framework of the AFSSaPS (the French Agency for Sanitary Safety of Health Products) should enable it to fully reach this goal.
Delbosc
A
A
Hôpital du Bocage, CHU de Dijon. arlette.delbosc@ufc-chu.univ.fcomte.fr
Weiller
J
J
Dussert
P
P
D000017:ABO Blood-Group System; D001771:Blood Banks / Q000331:legislation & jurisprudence / Q000592:standards*; D001782:Blood Donors / Q000331:legislation & jurisprudence; D001803:Blood Transfusion / Q000331:legislation & jurisprudence / Q000592:standards*; D017848:Blood-Borne Pathogens; D005602:France; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000592:standards; D012307:Risk Factors; D012308:Risk Management / Q000331:legislation & jurisprudence / Q000592:standards; D012449:Safety / Q000331:legislation & jurisprudence / Q000592:standards*
D000017:ABO Blood-Group System
L'hémovigilance à l'aube du XXIe siècle.